| Description | SARS-CoV-2 nsp13-IN-1 is an nsp13 with antiviral activity that inhibits the nsp13 ssDNA+ATPase, which can be used in the study of COVID-19 virus infection. |
| Target activity | ATPase:6±0.5 μM |
| molecular weight | 432.47 |
| Molecular formula | C27H20N4O2 |
| CAS | 1005304-44-8 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 30 mg/mL (69.37 mM), Sonication is recommended. |
| References | 1. Yazdi AK, et al. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infect Dis. 2022 Jul 13. |